During a meeting in Moscow on December 8, 2020, an agreement was reached between the Chairman of the Political Council of the Opposition Platform - For Life party Viktor Medvedchuk, Director of National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya Alexander Gintsburg and Director General of the Russian Direct Investment Fund Kirill Dmitriev on the possibility of producing a vaccine against COVID-19 Sputnik V at Kharkiv enterprise Biolik in Ukraine. Representatives of the Russian side announced their readiness to conclude an agreement on the transfer of technology and raw materials - a cell line for the production of vaccines in Ukraine. This became possible thanks to the activities of the joint Ukrainian-Russian working group created after the meeting of Russian President Vladimir Putin with Viktor Medvedchuk.
On January 2, 2021, Viktor Medvedchuk said that the pharmaceutical company Biolik had submitted an application to the Ministry of Health of Ukraine for registration of the Russian Sputnik V coronavirus vaccine for its production.
Kirill Dmitriev, the head of the Russian Direct Investment Fund, also said that they are ready to start joint clinical trials of a combination of the Sputnik V vaccine and the vaccine of English-Swedish company AstraZeneca in Ukraine, production of the vaccine in Ukraine and the possibility of using the combination of Sputnik V and AstraZeneca vaccines.
The agreement on the production of a vaccine in Ukraine and information on joint clinical trials of AstraZeneca and Sputnik V vaccines on the territory of Ukraine received wide publicity and caused a vivid reaction of the world media. The first to report this was Reuters, and later - another world agency Euronews, the largest news portal Yahoo, which posted this information in many languages, and CNN IBN.
This information sparked great interest in the United States and Canada, where the leading newspaper National Post, The Guardian, The Chronicle Herald, The Telegram and a number of others, as well as the Canadian YCNews Agency reported about it. The United States’ leading news outlet U.S. News & World Report and Metro widely covered this information, as well as a number of news networks of radio stations with several dozen broadcasters (Midwest Communications, Salem Radio Network, etc.), US business media, in particular the American business agrency Street Insider, Financial Editorial, trade and medical agencies.
Many European media outlets also wrote about this, including British Herald, the Swiss Broadcasting Corporation and a number of others.
The news also received a significant response in India, where the country's leading newspaper Hindustan Times, the influential business website Moneycontrol.com and the business newspaper Business_Standard, Microbiozindia websites, Reportwire and Devdiscourse wrote about it.
Arab media also reacted vividly to the information, in particular the Al Arabiya Network TV channel and Israeli The Jerusalem Post, as well as the media agencies in Africa and Asia, Turkey, Algeria, Malaysia, Singapore, the Philippines and other countries.
Such interest indicates that the international community treats the potential of the Russian Sputnik V vaccine seriously.
A number of media outlets and experts note that President Volodymyr Zelensky, Health Minister Maaksym Stepanov and Chief Sanitary Doctor Viktor Lyashko, who declare that Ukraine will not buy the Russian vaccine,as they have fallen into the trap of their own political bias being dependent on their overseas curators, they act in their interests instead of the interests of Ukrainian citizens. Although it is quite obvious that amidst the pandemic, the authorities must do everything to protect first of all Ukrainians, their lives and health.